IP Library Granted Patent US 11,939,323
Granted Patent B2
US 11,939,323 · App. 17/744,525 · Granted Mar 26, 2024

Methods of making a modulator of hemoglobin

Inventors: Xiang Wang (South San Francisco, CA); Shinji Fujimori (San Francisco, CA); Todd Daniel Nelson (Cream Ridge, NJ); Ana Cristina Parra Rivera (Plainsboro, NJ); Devon Mundal (Seattle, WA); Benjamin Graetz (San Mateo, CA); Morin M. Frick (San Mateo, CA)
Assignee: Global Blood Therapeutics, Inc.
C07D413/06
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,939,323
App. No.
17/744,525
Granted
Mar 26, 2024
Kind
B2
Abstract

The present disclosure relates to processes for preparing a compound of formula I: The disclosure also provides compounds that are synthetic intermediates.

Claims (56)

1. A process for preparing a compound of formula I:

comprising:

(i) contacting a compound of formula 1:

wherein X 1 is halo;

with a metalating reagent and carbon dioxide, wherein the metalating agent is a compound of formula X-M-R, and wherein M is a metal, R is an alkyl or aryl, and X is a halide or alkali metal, to form a compound of formula 2a:

(ii) contacting a compound of formula 2a with a compound of formula:

PG-X 2

wherein PG is a hydroxy protecting group and X 2 is halo;

to form a compound of formula 3:

(iii) contacting a compound of formula 3 with a compound of formula 4:

to form a compound of formula 5:

(iv) contacting a compound of formula 5 with a compound of formula 6:

to form a compound of formula 7:

and

(v) deprotecting a compound of formula 7 to form a compound of formula I.

2. The process of claim 1 , wherein the metalating agent is isopropyl magnesium chloride.

3. The process of claim 1 , wherein step (iii) comprise a coupling agent and a base.

4. The process of claim 1 , wherein step (iv) comprise triphenylphosphine and diisopropyl azodicarboxylate.

5. The process of claim 1 , wherein step (v) comprise tetrabutylammonium fluoride (TBAF).

6. A process for preparing a compound of formula I:

comprising:

(i) contacting a compound of formula 2:

wherein R 1 is hydroxy protecting group;

with a compound of formula 10:

or a salt thereof,

to form a compound of formula 11:

(ii) contacting a compound of formula 11 with a reductant to form a compound of formula 15:

and

(iii) deprotecting a compound of formula 15 to form a compound of formula I.

7. The process of claim 6 , wherein step (i) comprises a coupling agent and a base.

8. The process of claim 7 , wherein the coupling agent is propylphosphonic anhydride.

9. The process of claim 6 , wherein the reductant is lithium diisobutyl-t-butoxyaluminum hydride (LDBBA).

10. The process of claim 6 , wherein step (iii) comprise a deprotecting reagent, wherein the deprotecting reagent is tetrabutylammonium fluoride (TBAF).

11. A process for preparing a compound of formula I:

comprising:

(i) contacting a compound of formula 2:

wherein R 1 is hydroxy protecting group;

with a compound of formula 10:

or a salt thereof,

form a compound of formula 11:

(ii) contacting a compound of formula 11 with lithium diisobutyl-t-butoxyaluminum hydride (LDBBA) to provide a compound of formula I.

12. The process of claim 11 , wherein step (i) comprises a coupling agent and a base.

13. The process of claim 12 , wherein the coupling agent is propylphosphonic anhydride.

14. The process of claim 11 , wherein step (ii) further comprise a solvent selected from tetrahydrofuran (THF), 2-methyltetrahydrofuran, dichloromethane (DCM), methyl tert-butyl ether (MTBE), and ethyl acetate (EtOAc).

15. The process of claim 6 , wherein the hydroxy protecting group is tert-butyldiphenylsilyl (TBDPS), acetyl (Ac), or benzoyl (Bz).

16. The process of claim 6 , further comprising:

(iv) contacting a compound of formula 12:

with a compound of formula 13:

wherein:

R 2 is H; and R 3 is an amine protecting group;

to form a compound of formula 14:

and

(v) deprotecting a compound of formula 14 to form a compound of formula 10.

17. The process of claim 16 , wherein step (iv) comprise triphenylphosphine and diisopropyl azodicarboxylate.

18. The process of claim 16 , wherein step (v) comprise an acid.

19. The process of claim 18 , wherein the acid is methanesulfonic acid.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 16, 2022
From: XIANG WANG; FUJIMORI, SHINJI
To: GLOBAL BLOOD THERAPEUTICS, INC.
Reel/Frame 060825/0513 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 16, 2022
From: NELSON, TODD DANIEL; PARRA RIVERA, ANA CRISTINA
To: J-STAR RESEARCH, INC.
Reel/Frame 060825/0518 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 16, 2022
From: J-STAR RESEARCH, INC.
To: GLOBAL BLOOD THERAPEUTICS, INC.
Reel/Frame 060825/0522 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 16, 2022
From: MUNDAL, DEVON; GRAETZ, BENJAMIN; FRICK, MORIN M.
To: GLOBAL BLOOD THERAPEUTICS, INC.
Reel/Frame 060825/0527 →
Continuity (2)
Provisional Application 63188735 · May 14, 2021
Related Publication 20220388996A1 · Dec 8, 2022